|
Volumn 21, Issue 2, 2012, Pages 140-142
|
ASIRTing Control over Cancer Stem Cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
IMATINIB;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN P53;
SIRTUIN 1;
SONIC HEDGEHOG PROTEIN;
TENOVIN;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
AGING;
APOPTOSIS;
CANCER CONTROL;
CANCER DIAGNOSIS;
CANCER GROWTH;
CANCER STAGING;
CANCER STEM CELL;
CANCER SURVIVAL;
CD34 SELECTION;
CELL METABOLISM;
CELL PROLIFERATION;
CELL SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
COLONY FORMATION;
DNA REPAIR;
DRUG EFFICACY;
ENZYME INHIBITION;
EX VIVO STUDY;
GENE MUTATION;
HUMAN;
IN VITRO STUDY;
IN VIVO STUDY;
LEUKEMIA RELAPSE;
LOSS OF FUNCTION MUTATION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
TUMOR DIFFERENTIATION;
TUMOR ENGRAFTMENT;
TUMOR XENOGRAFT;
|
EID: 84856980339
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2012.01.014 Document Type: Short Survey |
Times cited : (11)
|
References (11)
|